Shariah Compliance Analysis of JAGSNPHARM.NS Stock
India Health Care Micro Cap
Yes. As of October 2026, Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Jagsonpal Pharmaceuticals Ltd passes Musaffa's business and financial screening criteria.
Jagsonpal Pharmaceuticals Ltd. engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. The company is headquartered in Gurgaon, Haryana. The firm is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
Jagsonpal Pharmaceuticals Ltd JAGSNPHARM.NS
₹219.10 ₹5.50 (2.45%) 1D
Last Updated: Oct 15, 12:00 AM·NSE
Pricing for IN stocks is delayed by 24 hours
JAGSNPHARM.NS Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Jagsonpal Pharmaceuticals Ltd is classified as halal.
Financial Metrics & Statements of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS)
FAQ's for Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS)
As of October 2026, Jagsonpal Pharmaceuticals Ltd JAGSNPHARM.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Jagsonpal Pharmaceuticals Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Jagsonpal Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Jagsonpal Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Jagsonpal Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Jagsonpal Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.